GERON CORP

GERN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.0B · 258 employees
351
SEC Filings
$1.31
Close 2026-09-22
258
Employees

Business Summary

Geron Corporation is a commercial-stage biopharmaceutical company focused on myeloid hematologic malignancies. The company commercializes RYTELO (imetelstat), a telomerase inhibitor, in the U.S. for the treatment of lower-risk myelodysplastic syndrome (MDS). RYTELO received FDA approval and a permanent J-Code (J0870) effective January 1, 2025. Geron also plans commercialization in the EU and is pursuing additional indications through clinical trials.

Latest Stock Quote

GERN 2026-09-22 $1.31 O:$1.32 H:$1.325 L:$1.29 Vol:6.2M VWAP:$1.3063
origin leaf: null

Next Earnings

expected 2026-11-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310000886744-26-000008EDGAR95K words
2025-02-272024-12-310000950170-25-027982EDGAR95K words
2024-02-282023-12-310000950170-24-022056EDGAR86K words
2023-03-162022-12-310000950170-23-008437EDGAR—
2022-03-102021-12-310001564590-22-009627EDGAR—
2021-03-112020-12-310001564590-21-012493EDGAR—
2020-03-122019-12-310001564590-20-010449EDGAR—
2019-03-072018-12-310001564590-19-006759EDGAR—
2018-03-162017-12-310001564590-18-006051EDGAR—
2017-03-012016-12-310001047469-17-001123EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300000886744-26-000037EDGAR58K words
2025-11-072025-09-300000886744-25-000071EDGAR60K words
2025-08-062025-06-300000886744-25-000052EDGAR58K words
2025-05-072025-03-310000886744-25-000010EDGAR57K words
2024-11-072024-09-300000950170-24-123282EDGAR62K words
2024-08-082024-06-300000950170-24-093950EDGAR58K words
2024-05-022024-03-310000950170-24-052074EDGAR51K words
2023-11-022023-09-300000950170-23-057760EDGAR63K words
2023-08-032023-06-300000950170-23-037931EDGAR66K words
2023-05-112023-03-310000950170-23-020853EDGAR—
2022-11-072022-09-300000950170-22-022712EDGAR—
2022-08-112022-06-300000950170-22-016839EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001193125-26-336508EDGAR3K words
2026-03-260001193125-26-125151EDGAR1K words
2026-02-250001193125-26-068523EDGAR3K words
2026-01-120000886744-26-000003EDGAR2K words
2026-01-060001193125-26-003388EDGAR1K words
2025-12-160000886744-25-000074EDGAR1K words
2025-11-050000886744-25-000068EDGAR3K words
2025-10-140001628280-25-044862EDGAR2K words
2025-08-060000886744-25-000054EDGAR12K words
2025-08-060000886744-25-000048EDGAR3K words

351 total filings indexed. 319 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

myeloid-hematologic-malignancies lower-risk-myelodysplastic-syndrome-(mds) oncology/hematology-pharmaceuticals u.s.-pharmaceutical-market european-union-pharmaceutical-market proprietary-oligonucleotide-chemistry telomere-and-telomerase-biology

Company Identity

CIK0000886744
TickerGERN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.geron.com
Listed1996-07-31

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 3b626bc12492b2544dcba991f4be5d6c402575bb4627725c2d77637a06fb3600
parent: 4d9ed937b805ea0be77e7b5aa728e42287063d25b8b1b84786a75e159a10fc33
content hash: 5f4cb2fea19ab10154dade407f7d3c731e85001b4048d960fe1b89f707050591
signed: 2026-09-28T12:01:25.734Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GERN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GERN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GERN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.